140 related articles for article (PubMed ID: 9079716)
1. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice.
Nuijens JH; van Berkel PH; Geerts ME; Hartevelt PP; de Boer HA; van Veen HA; Pieper FR
J Biol Chem; 1997 Mar; 272(13):8802-7. PubMed ID: 9079716
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.
van Berkel PH; Geerts ME; van Veen HA; Kooiman PM; Pieper FR; de Boer HA; Nuijens JH
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):107-14. PubMed ID: 7492299
[TBL] [Abstract][Full Text] [Related]
3. Large scale production of recombinant human lactoferrin in the milk of transgenic cows.
van Berkel PH; Welling MM; Geerts M; van Veen HA; Ravensbergen B; Salaheddine M; Pauwels EK; Pieper F; Nuijens JH; Nibbering PH
Nat Biotechnol; 2002 May; 20(5):484-7. PubMed ID: 11981562
[TBL] [Abstract][Full Text] [Related]
4. Differential glycosylation of rhLf expressed in the mammary gland of transgenic mice.
Zhao C; Liu Z; Fan B; Dai Y; Wang L; Zheng M; Wang M; Niu H; Xi F; Li N; Zhang D
Anim Biotechnol; 2006; 17(1):13-20. PubMed ID: 16621756
[TBL] [Abstract][Full Text] [Related]
5. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.
Thomassen EA; van Veen HA; van Berkel PH; Nuijens JH; Abrahams JP
Transgenic Res; 2005 Aug; 14(4):397-405. PubMed ID: 16201406
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle.
Yu T; Guo C; Wang J; Hao P; Sui S; Chen X; Zhang R; Wang P; Yu G; Zhang L; Dai Y; Li N
Glycobiology; 2011 Feb; 21(2):206-24. PubMed ID: 20943674
[TBL] [Abstract][Full Text] [Related]
7. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
[TBL] [Abstract][Full Text] [Related]
8. Recombinant functional human lactoferrin expressed in baculovirus system.
Liu T; Zhang YZ; Wu XF
Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):201-6. PubMed ID: 16518545
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant human lactoferrin N-glycans expressed in the milk of transgenic cows.
Parc AL; Karav S; Rouquié C; Maga EA; Bunyatratchata A; Barile D
PLoS One; 2017; 12(2):e0171477. PubMed ID: 28170415
[TBL] [Abstract][Full Text] [Related]
10. Expression of active recombinant human lactoferrin in the milk of transgenic goats.
Zhang J; Li L; Cai Y; Xu X; Chen J; Wu Y; Yu H; Yu G; Liu S; Zhang A; Chen J; Cheng G
Protein Expr Purif; 2008 Feb; 57(2):127-35. PubMed ID: 18054499
[TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies against human lactoferrin.
van Berkel PH; van Veen HA; Geerts ME; Nuijens JH
J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435
[TBL] [Abstract][Full Text] [Related]
12. Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin.
van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
Anal Biochem; 2002 Oct; 309(1):60-6. PubMed ID: 12381362
[TBL] [Abstract][Full Text] [Related]
13. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of human lactoferrin in milk of transgenic mice using genomic lactoferrin sequence.
Kim SJ; Sohn BH; Jeong S; Pak KW; Park JS; Park IY; Lee TH; Choi YH; Lee CS; Han YM; Yu DY; Lee KK
J Biochem; 1999 Aug; 126(2):320-5. PubMed ID: 10423524
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.
van Berkel PH; van Veen HA; Geerts ME; de Boer HA; Nuijens JH
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):117-22. PubMed ID: 8870657
[TBL] [Abstract][Full Text] [Related]
16. Production of human lactoferrin in animal milk.
Goldman IL; Georgieva SG; Gurskiy YG; Krasnov AN; Deykin AV; Popov AN; Ermolkevich TG; Budzevich AI; Chernousov AD; Sadchikova ER
Biochem Cell Biol; 2012 Jun; 90(3):513-9. PubMed ID: 22360490
[TBL] [Abstract][Full Text] [Related]
17. The dominant expression of functional human lactoferrin in transgenic cloned goats using a hybrid lactoferrin expression construct.
Yu H; Chen J; Sun W; Liu S; Zhang A; Xu X; Wang X; He Z; Liu G; Cheng G
J Biotechnol; 2012 Oct; 161(3):198-205. PubMed ID: 22789477
[TBL] [Abstract][Full Text] [Related]
18. Large-scale production of recombinant human lactoferrin from high-expression, marker-free transgenic cloned cows.
Wang M; Sun Z; Yu T; Ding F; Li L; Wang X; Fu M; Wang H; Huang J; Li N; Dai Y
Sci Rep; 2017 Sep; 7(1):10733. PubMed ID: 28878310
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
